These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 23298392)

  • 1. Plasma PCSK9 concentrations during an oral fat load and after short term high-fat, high-fat high-protein and high-fructose diets.
    Cariou B; Langhi C; Le Bras M; Bortolotti M; Lê KA; Theytaz F; Le May C; Guyomarc'h-Delasalle B; Zaïr Y; Kreis R; Boesch C; Krempf M; Tappy L; Costet P
    Nutr Metab (Lond); 2013 Jan; 10(1):4. PubMed ID: 23298392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High protein intake reduces intrahepatocellular lipid deposition in humans.
    Bortolotti M; Kreis R; Debard C; Cariou B; Faeh D; Chetiveaux M; Ith M; Vermathen P; Stefanoni N; Lê KA; Schneiter P; Krempf M; Vidal H; Boesch C; Tappy L
    Am J Clin Nutr; 2009 Oct; 90(4):1002-10. PubMed ID: 19710199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes.
    Lê KA; Ith M; Kreis R; Faeh D; Bortolotti M; Tran C; Boesch C; Tappy L
    Am J Clin Nutr; 2009 Jun; 89(6):1760-5. PubMed ID: 19403641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nutritional and Lipid Modulation of PCSK9: Effects on Cardiometabolic Risk Factors.
    Krysa JA; Ooi TC; Proctor SD; Vine DF
    J Nutr; 2017 Apr; 147(4):473-481. PubMed ID: 28179493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma proprotein convertase subtilisin kexin type 9 levels are related to markers of cholesterol synthesis in familial combined hyperlipidemia.
    Brouwers MC; Konrad RJ; van Himbergen TM; Isaacs A; Otokozawa S; Troutt JS; Schaefer EJ; van Greevenbroek MM; Stalenhoef AF; de Graaf J
    Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1115-21. PubMed ID: 23333725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary high oleic canola oil supplemented with docosahexaenoic acid attenuates plasma proprotein convertase subtilisin kexin type 9 (PCSK9) levels in participants with cardiovascular disease risk: A randomized control trial.
    Pu S; Rodríguez-Pérez C; Ramprasath VR; Segura-Carretero A; Jones PJ
    Vascul Pharmacol; 2016 Dec; 87():60-65. PubMed ID: 27374222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treadmill Exercise Training Modulates Hepatic Cholesterol Metabolism and Circulating PCSK9 Concentration in High-Fat-Fed Mice.
    Wen S; Jadhav KS; Williamson DL; Rideout TC
    J Lipids; 2013; 2013():908048. PubMed ID: 23862065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma proprotein convertase subtilisin-kexin type 9 does not change during 24h insulin infusion in healthy subjects and type 2 diabetic patients.
    Kappelle PJ; Lambert G; Dullaart RP
    Atherosclerosis; 2011 Feb; 214(2):432-5. PubMed ID: 21122860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Dietary Protein and Fat Content on Intrahepatocellular and Intramyocellular Lipids during a 6-Day Hypercaloric, High Sucrose Diet: A Randomized Controlled Trial in Normal Weight Healthy Subjects.
    Surowska A; Jegatheesan P; Campos V; Marques AS; Egli L; Cros J; Rosset R; Lecoultre V; Kreis R; Boesch C; Pouymayou B; Schneiter P; Tappy L
    Nutrients; 2019 Jan; 11(1):. PubMed ID: 30669704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating proprotein convertase subtilisin kexin type 9 has a diurnal rhythm synchronous with cholesterol synthesis and is reduced by fasting in humans.
    Persson L; Cao G; Ståhle L; Sjöberg BG; Troutt JS; Konrad RJ; Gälman C; Wallén H; Eriksson M; Hafström I; Lind S; Dahlin M; Amark P; Angelin B; Rudling M
    Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2666-72. PubMed ID: 20884874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the proprotein convertase subtilisin/kexin type 9 for the treatment of dyslipidemia and atherosclerosis.
    Urban D; Pöss J; Böhm M; Laufs U
    J Am Coll Cardiol; 2013 Oct; 62(16):1401-8. PubMed ID: 23973703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dyslipidemia in rat fed with high-fat diet is not associated with PCSK9-LDL-receptor pathway but ageing.
    Jia YJ; Liu J; Guo YL; Xu RX; Sun J; Li JJ
    J Geriatr Cardiol; 2013 Dec; 10(4):361-8. PubMed ID: 24454330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressor of Cytokine Signaling-3 (SOCS-3) Induces Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Expression in Hepatic HepG2 Cell Line.
    Ruscica M; Ricci C; Macchi C; Magni P; Cristofani R; Liu J; Corsini A; Ferri N
    J Biol Chem; 2016 Feb; 291(7):3508-19. PubMed ID: 26668321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid stimulating hormone exhibits the impact on LDLR/LDL-c via up-regulating hepatic PCSK9 expression.
    Gong Y; Ma Y; Ye Z; Fu Z; Yang P; Gao B; Guo W; Hu D; Ye J; Ma S; Zhang F; Zhou L; Xu X; Li Z; Yang T; Zhou H
    Metabolism; 2017 Nov; 76():32-41. PubMed ID: 28987238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of short-term overfeeding with fructose, fat and fructose plus fat on plasma and hepatic lipids in healthy men.
    Sobrecases H; Lê KA; Bortolotti M; Schneiter P; Ith M; Kreis R; Boesch C; Tappy L
    Diabetes Metab; 2010 Jun; 36(3):244-6. PubMed ID: 20483648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver fat accumulation is associated with circulating PCSK9.
    Ruscica M; Ferri N; Macchi C; Meroni M; Lanti C; Ricci C; Maggioni M; Fracanzani AL; Badiali S; Fargion S; Magni P; Valenti L; Dongiovanni P
    Ann Med; 2016 Aug; 48(5):384-91. PubMed ID: 27222915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum proprotein convertase subtilisin/kexin type 9 concentration is not increased by plant stanol ester consumption in normo- to moderately hypercholesterolaemic non-obese subjects. The BLOOD FLOW intervention study.
    Simonen P; Stenman UH; Gylling H
    Clin Sci (Lond); 2015 Sep; 129(5):439-46. PubMed ID: 25857271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma proprotein convertase subtilisin/kexin type 9 is associated with Lp(a) in type 2 diabetic patients.
    Nekaies Y; Baudin B; Kelbousi S; Sakly M; Attia N
    J Diabetes Complications; 2015; 29(8):1165-70. PubMed ID: 26412029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proprotein Convertase Subtilisin/Kexin-Type 9 and Lipid Metabolism.
    Guo S; Xia XD; Gu HM; Zhang DW
    Adv Exp Med Biol; 2020; 1276():137-156. PubMed ID: 32705598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fasting reduces plasma proprotein convertase, subtilisin/kexin type 9 and cholesterol biosynthesis in humans.
    Browning JD; Horton JD
    J Lipid Res; 2010 Nov; 51(11):3359-63. PubMed ID: 20716520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.